TiCARos Co.Ltd is a biotech company which develops the next generation immunotherapeutics for cancers. TiCARos develops matchless CAR-T and cell therapeutics for cancer treatment, by leveraging accumulated experiences and technologies of the immunologists at Seoul National University, College of Medicine. We hope that these efforts will lead to a novel breakthrough in treatment of not only intractable hematologic malignancies but also of advanced solid tumors.
TiCARos
Category:
Venture
Main Business Area
TiCARos proposes a new treatment option using cutting-edge technology in immunology and antibody-engineering. TiCARos develops best-in class, first-in class therapies based on Converter CAR platform for better T cell activity and on CLIP CAR platform for more stable immune synapse of CAR-T cells.
| Contact Details | 11th Floor, Seongsoo AK valley, 76, Yeonmujang-gil, Seongdong-gu, Seoul http://www.ticaros.com/02-745-6655admin@ticaros.com |
|---|
Find out more companies
Related products
-
-
-
-
VentureAprogen
Their main modalities include SDR-Grafting, Recombinant Protein Fusion, CHIMPS Bispecific Antibodies, SHOCAP Bispecific Antibodies, and Bitargeting Receptor-Antibody Hybrid
-
